- Home
- WATT vs TRAW Comparison
WATT vs TRAW Comparison
Compare WATT & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WATT
- TRAW
- Stock Information
- Founded
- WATT 2012
- TRAW 1998
- Country
- WATT United States
- TRAW United States
- Employees
- WATT N/A
- TRAW N/A
- Industry
- WATT Radio And Television Broadcasting And Communications Equipment
- TRAW
- Sector
- WATT Technology
- TRAW
- Exchange
- WATT Nasdaq
- TRAW NYSE
- Market Cap
- WATT 9.1M
- TRAW 10.1M
- IPO Year
- WATT 2014
- TRAW 2013
- Fundamental
- Price
- WATT $0.30
- TRAW $1.53
- Analyst Decision
- WATT Strong Buy
- TRAW
- Analyst Count
- WATT 2
- TRAW 0
- Target Price
- WATT $2.25
- TRAW N/A
- AVG Volume (30 Days)
- WATT 882.0K
- TRAW 56.6K
- Earning Date
- WATT 05-13-2025
- TRAW 05-14-2025
- Dividend Yield
- WATT N/A
- TRAW N/A
- EPS Growth
- WATT N/A
- TRAW N/A
- EPS
- WATT N/A
- TRAW N/A
- Revenue
- WATT $768,000.00
- TRAW $226,000.00
- Revenue This Year
- WATT $1,028.91
- TRAW $3.81
- Revenue Next Year
- WATT N/A
- TRAW $30.43
- P/E Ratio
- WATT N/A
- TRAW N/A
- Revenue Growth
- WATT 62.02
- TRAW N/A
- 52 Week Low
- WATT $0.12
- TRAW $1.52
- 52 Week High
- WATT $2.70
- TRAW $19.44
- Technical
- Relative Strength Index (RSI)
- WATT 52.88
- TRAW 29.51
- Support Level
- WATT $0.24
- TRAW $1.44
- Resistance Level
- WATT $0.28
- TRAW $2.63
- Average True Range (ATR)
- WATT 0.04
- TRAW 0.30
- MACD
- WATT 0.01
- TRAW 0.03
- Stochastic Oscillator
- WATT 100.00
- TRAW 7.56
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. Its products include Transmitter IC & Module, Receivers IC, Transmitter System and other tools.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.